Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vanderbilt

Showing results (421-430 of 452) with videos related to

Pageof 46
Sort By:
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 24, 2026
Pulmonary Solid and Granular Adenocarcinomas Expressing HepPar1: Highly Aggressive Tumors Exhibiting Mitochondrial Adaptation to STK11 Mutations rather than Hepatoid DifferentiationChristopher A Febres-Aldana, Chad M Vanderbilt, Rania Aly, et al.
Acta Neuropathologica Communications|November 10, 2020
Genetic and epigenetic landscape of IDH-wildtype glioblastomas with FGFR3-TACC3 fusionsDouglas A Mata, Jamal K Benhamida, Andrew L Lin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 29, 2023
Assessing the Genomic Landscape of Cervical Cancers: Clinical Opportunities and Therapeutic TargetsClaire F Friedman, Vignesh Ravichandran, Kathryn Miller, et al.
Molecular Cancer Therapeutics|September 16, 2008
Antixenograft tumor activity of a humanized anti-insulin-like growth factor-I receptor monoclonal antibody is associated with decreased AKT activation and glucose uptakeYonglei Shang, Yifan Mao, Jennifer Batson, et al.
Bladder Cancer (Amsterdam, Netherlands)|January 24, 2022
<i>CD274</i> (<i>PD-L1</i>) Copy Number Changes (Gain) & Response to Immune Checkpoint Blockade Therapy in Carcinomas of the Urinary TractSounak Gupta, Chad M Vanderbilt, Yanming Zhang, et al.
Nature Medicine|July 9, 2025
Real-world deployment of a fine-tuned pathology foundation model for lung cancer biomarker detectionGabriele Campanella, Neeraj Kumar, Swaraj Nanda, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 13, 2022
Comprehensive Molecular Characterization of Gallbladder Carcinoma and Potential Targets for InterventionNicolas A Giraldo, Esther Drill, Baby A Satravada, et al.
Human Pathology|April 2, 2021
Assessment of isochromosome 12p and 12p abnormalities in germ cell tumors using fluorescence in situ hybridization, single-nucleotide polymorphism arrays, and next-generation sequencing/mate-pair sequencingC Eric Freitag, William R Sukov, Alan H Bryce, et al.
The Journal of Molecular Diagnostics : JMD|November 20, 2020
Routine Evaluation of Minimal Residual Disease in Myeloma Using Next-Generation Sequencing Clonality Testing: Feasibility, Challenges, and Direct Comparison with High-Sensitivity Flow CytometryCaleb Ho, Mustafa Syed, Mikhail Roshal, et al.
NPJ Precision Oncology|February 12, 2024
Genomic and epigenomic basis of breast invasive lobular carcinomas lacking CDH1 genetic alterationsHiginio Dopeso, Andrea M Gazzo, Fatemeh Derakhshan, et al.
Pageof 46

Showing results (421-430 of 452) with videos related to

Sort By:
Pageof 46
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 24, 2026
Pulmonary Solid and Granular Adenocarcinomas Expressing HepPar1: Highly Aggressive Tumors Exhibiting Mitochondrial Adaptation to STK11 Mutations rather than Hepatoid DifferentiationChristopher A Febres-Aldana, Chad M Vanderbilt, Rania Aly, et al.
Acta Neuropathologica Communications|November 10, 2020
Genetic and epigenetic landscape of IDH-wildtype glioblastomas with FGFR3-TACC3 fusionsDouglas A Mata, Jamal K Benhamida, Andrew L Lin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 29, 2023
Assessing the Genomic Landscape of Cervical Cancers: Clinical Opportunities and Therapeutic TargetsClaire F Friedman, Vignesh Ravichandran, Kathryn Miller, et al.
Molecular Cancer Therapeutics|September 16, 2008
Antixenograft tumor activity of a humanized anti-insulin-like growth factor-I receptor monoclonal antibody is associated with decreased AKT activation and glucose uptakeYonglei Shang, Yifan Mao, Jennifer Batson, et al.
Bladder Cancer (Amsterdam, Netherlands)|January 24, 2022
<i>CD274</i> (<i>PD-L1</i>) Copy Number Changes (Gain) & Response to Immune Checkpoint Blockade Therapy in Carcinomas of the Urinary TractSounak Gupta, Chad M Vanderbilt, Yanming Zhang, et al.
Nature Medicine|July 9, 2025
Real-world deployment of a fine-tuned pathology foundation model for lung cancer biomarker detectionGabriele Campanella, Neeraj Kumar, Swaraj Nanda, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 13, 2022
Comprehensive Molecular Characterization of Gallbladder Carcinoma and Potential Targets for InterventionNicolas A Giraldo, Esther Drill, Baby A Satravada, et al.
Human Pathology|April 2, 2021
Assessment of isochromosome 12p and 12p abnormalities in germ cell tumors using fluorescence in situ hybridization, single-nucleotide polymorphism arrays, and next-generation sequencing/mate-pair sequencingC Eric Freitag, William R Sukov, Alan H Bryce, et al.
The Journal of Molecular Diagnostics : JMD|November 20, 2020
Routine Evaluation of Minimal Residual Disease in Myeloma Using Next-Generation Sequencing Clonality Testing: Feasibility, Challenges, and Direct Comparison with High-Sensitivity Flow CytometryCaleb Ho, Mustafa Syed, Mikhail Roshal, et al.
NPJ Precision Oncology|February 12, 2024
Genomic and epigenomic basis of breast invasive lobular carcinomas lacking CDH1 genetic alterationsHiginio Dopeso, Andrea M Gazzo, Fatemeh Derakhshan, et al.
Pageof 46